In established orthotopic pancreatic tumors, we found that knockdown of IGFBP-2 led to smaller tumor size, lighter tumor weight, and decreased the expression of Ki-67 in immunohistochemical analysis. The gene discussed is MKI67; the disease is neoplasm.